https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Classification of schizophrenia using differential gene expression in peripheral blood lymphocytes https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:2967 Wed 24 Jul 2013 22:50:59 AEST ]]> The genetic architecture of the human cerebral cortex https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42676 Wed 22 Mar 2023 14:34:07 AEDT ]]> Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48900 Wed 19 Apr 2023 16:40:13 AEST ]]> Genetic markers of human evolution are enriched in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25928 −9) more prevalent in genomic regions that are likely to have undergone recent positive selection in humans (i.e., with a low NSS score). Variants in brain-related genes with a low NSS score confer significantly higher susceptibility than variants in other brain-related genes. The enrichment is strongest for schizophrenia, but we cannot rule out enrichment for other phenotypes. The false discovery rate conditional on the evolutionary proxy points to 27 candidate schizophrenia susceptibility loci, 12 of which are associated with schizophrenia and other psychiatric disorders or linked to brain development. Conclusions: Our results suggest that there is a polygenic overlap between schizophrenia and NSS score, a marker of human evolution, which is in line with the hypothesis that the persistence of schizophrenia is related to the evolutionary process of becoming human.]]> Wed 12 Aug 2020 09:42:59 AEST ]]> Upregulation of dicer and MicroRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11770 Wed 11 Apr 2018 17:17:57 AEST ]]> Leveraging genomic annotations and pleiotropic enrichment for improved replication rates in schizophrenia GWAS https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26719 -8). There were 693 and 219 independent loci with model-based replication rates ≥80% and ≥90%, respectively. Compared to analyses not incorporating relative enrichment scores, CM3 increased out-of-sample yield for SNPs that replicate at a given rate. This demonstrates that replication probabilities can be more accurately estimated using prior enrichment information with CM3.]]> Wed 11 Apr 2018 17:05:48 AEST ]]> Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23292 Wed 11 Apr 2018 15:09:07 AEST ]]> Antipsychotic drug-associated gene-miRNA interaction in T-lymphocytes https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18037 Wed 11 Apr 2018 14:27:24 AEST ]]> Estimating effect sizes and expected replication probabilities from GWAS summary statistics https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29038 Wed 11 Apr 2018 14:13:00 AEST ]]> Gene expression profiling of Xeroderma pigmentosum https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1111 Wed 11 Apr 2018 13:29:26 AEST ]]> Alternative mRNA fates identified in microRNA-associated transcriptome analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15192 Wed 11 Apr 2018 11:39:00 AEST ]]> Altered gene expression in the superior temporal gyrus in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:4362 Wed 11 Apr 2018 11:36:43 AEST ]]> Different forms of glycine- and GABAᴀ-receptor mediated inhibitory synaptic transmission in mouse superficial and deep dorsal horn neurons https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7526 Wed 11 Apr 2018 10:11:50 AEST ]]> Genome-wide association studies suggest limited immune gene enrichment in schizophrenia compared to 5 autoimmune diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29042 Wed 11 Apr 2018 09:36:12 AEST ]]> Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15118 Wed 11 Apr 2018 09:18:27 AEST ]]> Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54632 Wed 06 Mar 2024 10:59:47 AEDT ]]> DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48767 Wed 05 Apr 2023 13:55:36 AEST ]]> Attention: schizophrenia risk gene product miR-137 now targeting EFNB2 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33390 Wed 04 Sep 2019 10:12:38 AEST ]]> Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44746 Tue 21 Mar 2023 16:53:58 AEDT ]]> Schizophrenia-associated MicroRNA–Gene Interactions in the Dorsolateral Prefrontal Cortex https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45935 Tue 08 Nov 2022 10:00:10 AEDT ]]> Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46890 Tue 06 Dec 2022 12:02:52 AEDT ]]> Late gestation immune activation increases IBA1-positive immunoreactivity levels in the corpus callosum of adult rat offspring https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33669 Iba1, Gfap, IL1-β and TNF-α mRNA levels in the cingulate cortex (CC) in adult offspring exposed to maternal immune activation. Prenatal exposure to immune activation had a significant main effect on microglial IBA1-positive immunoreactive material (IBA1+IRM) in the corpus callosum; post-hoc analyses identified a significant increase in GD19 offspring, but not GD10. No change in was observed in the CC. In contrast, maternal immune activation had a significant main effect on GFAP+IRM in the CC at GD19 (not GD10); post-hoc analyses only identified a strong trend towards increased GFAP+IRM in the GD19 offspring, with no white matter changes. This suggests late gestation maternal immune activation causes subtle alterations to microglia and astrocytes in the adult offspring.]]> Tue 04 Jun 2019 13:36:19 AEST ]]> Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34283 −15), which persisted after excluding loci implicated in previous studies (OR = 1.07, P = 1.7 × 10−6). CNV burden was enriched for genes associated with synaptic function (OR = 1.68, P = 2.8 × 10−11) and neurobehavioral phenotypes in mouse (OR = 1.18, P = 7.3 × 10−5). Genome-wide significant evidence was obtained for eight loci, including 1q21.1, 2p16.3 (NRXN1), 3q29, 7q11.2, 15q13.3, distal 16p11.2, proximal 16p11.2 and 22q11.2. Suggestive support was found for eight additional candidate susceptibility and protective loci, which consisted predominantly of CNVs mediated by nonallelic homologous recombination.]]> Tue 03 Sep 2019 18:30:49 AEST ]]> Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) consortium https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33388 Tue 03 Sep 2019 17:54:11 AEST ]]> A correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33389 Tue 03 Sep 2019 17:54:01 AEST ]]> Reduced cortical somatostatin gene expression in a rat model of maternal immune activation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46136 Thu 29 Jun 2023 12:51:13 AEST ]]> The effects of haloperidol treatment on the distribution of NK1 receptor immunoreactive neurons in guinea-pig brain (Short communication) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:534 Thu 25 Jul 2013 09:10:32 AEST ]]> Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47202 Thu 15 Dec 2022 11:18:18 AEDT ]]> ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines. https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54816 Thu 14 Mar 2024 14:38:44 AEDT ]]> A polygenic resilience score moderates the genetic risk for schizophrenia: Replication in 18,090 cases and 28,114 controls from the Psychiatric Genomics Consortium https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54811 Thu 14 Mar 2024 14:24:56 AEDT ]]> Identification of gene loci that overlap between schizophrenia and educational attainment https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34615 Thu 04 Apr 2019 09:04:20 AEDT ]]> Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7882 Sat 24 Mar 2018 08:41:34 AEDT ]]> Investigation of the expression of genes affecting cytomatrix active zone function in the amygdala in schizophrenia: effects of antipsychotic drugs https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7124 Sat 24 Mar 2018 08:34:10 AEDT ]]> Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1288 Sat 24 Mar 2018 08:32:45 AEDT ]]> Increased tachykinin NK1 receptor immunoreactivity in the prefrontal cortex in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1083 Sat 24 Mar 2018 08:32:10 AEDT ]]> Altered gene expression in the amygdala in schizophrenia: up-regulation of genes located in the cytomatrix active zone https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1231 Sat 24 Mar 2018 08:28:34 AEDT ]]> Localisation of tachykinin NK₁ and NK₃ receptors in the human prefrontal and visual cortex https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:2883 Sat 24 Mar 2018 08:27:40 AEDT ]]> Preliminary evidence of an interaction between the FOXP2 gene and childhood emotional abuse predicting likelihood of auditory verbal hallucinations in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20953 Sat 24 Mar 2018 08:06:07 AEDT ]]> Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21387 Catechol-O-methyltransferase (COMT) Val158Met polymorphism, a common genetic variant known to affect cognition and prefrontal dopamine levels. Participants were 429 schizophrenia/schizoaffective cases from the Australian Schizophrenia Research Bank (ASRB). Cognitive performance was assessed using the Repeatable Battery for Assessment of Neuropsychological Status (RBANS), Controlled Oral Word Association Test (COWAT), Letter Number Sequencing (LNS) test, and the Wechsler Test of Adult Reading (WTAR). Hierarchical regression was used to test the main effects and additive interaction effects of genotype and childhood trauma in the domains of physical abuse, emotional abuse, and emotional neglect, on cognition and symptom profiles of clinical cases. Consistent with previous findings, COMT Val homozygotes performed worse on cognitive measures in the absence of childhood adversity. In addition, a significant interaction between COMT genotype and physical abuse was associated with better executive function in Val homozygotes, relative to those of the same genotype with no history of abuse. Finally, the severity of positive symptoms was greater in Met carriers who had experienced physical abuse, and the severity of negative symptoms in Met carriers was greater in the presence of emotional neglect. These results suggest that the possible epigenetic modulation of the expression of the COMT Val158Met polymorphism and consequent effects on cognition and symptoms in schizophrenia, with worse outcomes associated with adverse childhood experiences in Met carriers.]]> Sat 24 Mar 2018 08:05:04 AEDT ]]> Combined analysis of exon splicing and genome wide polymorphism data predict schizophrenia risk loci. https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:17373 Sat 24 Mar 2018 08:01:32 AEDT ]]> Age effects on cerebral grey matter and their associations with psychopathology, cognition and treatment response in previously untreated schizophrenia patients https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20972 Sat 24 Mar 2018 07:54:21 AEDT ]]> Design and interpretation of microRNA-reporter gene activity https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20136 Sat 24 Mar 2018 07:51:34 AEDT ]]> Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20133 Sat 24 Mar 2018 07:51:34 AEDT ]]> Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20137 Sat 24 Mar 2018 07:51:34 AEDT ]]> Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20134 Sat 24 Mar 2018 07:51:33 AEDT ]]> Context-specific microRNA function in developmental complexity https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20135 Sat 24 Mar 2018 07:51:32 AEDT ]]> Dysregulation of miRNA 181b in the temporal cortex in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:5407 Sat 24 Mar 2018 07:48:18 AEDT ]]> Do common genotypes of FK506 binding protein 5 (FKBP5) moderate the effects of childhood maltreatment on cognition in schizophrenia and healthy controls? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26307 Sat 24 Mar 2018 07:40:40 AEDT ]]> Increased white matter neuron density in a rat model of maternal immune activation - implications for schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26149 +) and somatostatin (SST+) IWMNs was determined in the white matter of the corpus callosum in two rostrocaudally adjacent areas in the 12week old offspring of GD10 (n=10) or GD19 polyI:C dams (n=18) compared to controls (n=20). NeuN+ IWMN density trended to be higher in offspring from dams exposed to polyI:C at GD19, but not GD10. A subpopulation of these NeuN+ IWMNs was shown to express SST. PolyI:C treatment of dams induced a significant increase in the density of SST+ IWMNs in the offspring when delivered at both gestational stages with more regionally widespread effects observed at GD19. A positive correlation was observed between NeuN+ and SST+ IWMN density in animals exposed to polyI:C at GD19, but not controls. This is the first study to show that MIA increases IWMN density in adult offspring in a similar manner to that seen in the brain in schizophrenia. This suggests the MIA model will be useful in future studies aimed at probing the relationship between IWMNs and schizophrenia.]]> Sat 24 Mar 2018 07:35:26 AEDT ]]> Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29335 Sat 24 Mar 2018 07:34:19 AEDT ]]> CX3CR1 is dysregulated in blood and brain from schizophrenia patients https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27390 Sat 24 Mar 2018 07:34:09 AEDT ]]> Schizophrenia risk from complex variation of complement component 4 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30050 Sat 24 Mar 2018 07:31:15 AEDT ]]> LD score regression distinguishes confounding from polygenicity in genome-wide association studies https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28311 Sat 24 Mar 2018 07:27:06 AEDT ]]> Partitioning heritability by functional annotation using genome-wide association summary statistics https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23306 Sat 24 Mar 2018 07:16:19 AEDT ]]> Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23305 Sat 24 Mar 2018 07:16:19 AEDT ]]> Altered neural signaling and immune pathways in peripheral blood mononuclear cells of schizophrenia patients with cognitive impairment: a transcriptome analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25081 Sat 24 Mar 2018 07:15:04 AEDT ]]> Finding the needle in the haystack: a review of microarray gene expression research into schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22172 Sat 24 Mar 2018 07:14:59 AEDT ]]> The effect of a muscarinic receptor 1 gene variant on grey matter volume in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22690 A single nucleotide polymorphism (rs2067477) within the cholinergic muscarinic M1 receptor (CHRM1) perform less well on the Wisconsin Card Sorting Test (WCST) than those who are heterozygous. This study sought to determine whether variation in the rs2067477 genotype was associated with differential changes in brain structure. Data from 227 patients with established schizophrenia or schizoaffective disorder were obtained from the Australian Schizophrenia Research Bank. Whole-brain voxel-based morphometry was performed to compare regional grey matter volume (GMV) between the 267C/C (N=191) and 267C/A (N=36) groups. Secondary analyses tested for an effect of genotype on cognition (the WCST was not available). Individuals who were homozygous (267C/C) demonstrated significantly reduced GMV in the right precentral gyrus compared to those who were heterozygous (267C/A). These preliminary results suggest that the rs2067477 genotype is associated with brain structure in the right precentral gyrus in individuals with schizophrenia/schizoaffective disorder. Future studies are required to replicate these results and directly link the volumetric reductions with specific cognitive processes.]]> Sat 24 Mar 2018 07:11:11 AEDT ]]> Wnt receptor gene FZD1 was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44131 Sat 08 Oct 2022 12:36:32 AEDT ]]> The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42338 N = 29,125 cases and 34,836 controls), a robust polygenic signal was observed from gene sets based on TCF4, FMR1, upregulation from MIR137 and downregulation from CHD8. Additional analyses revealed a constant floor effect in the amount of variance explained, consistent with the omnigenic model. Thus, we report that putative core gene sets showed a significant effect above and beyond the floor effect that might be linked with the underlying omnigenic background. In addition, we demonstrate a method to quantify the contribution of specific gene sets within the omnigenic context.]]> Mon 22 Aug 2022 14:00:20 AEST ]]> Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50972 Mon 14 Aug 2023 15:19:39 AEST ]]> White matter neuron biology and neuropathology in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35822 Mon 09 Dec 2019 16:39:38 AEDT ]]> Comparison between [⁶⁸Ga]Ga-PSMA-617 and [¹⁸F]FET PET as Imaging Biomarkers in Adult Recurrent Glioblastoma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55074 Mon 08 Apr 2024 14:10:37 AEST ]]> A molecule-based genetic association approach implicates a range of voltage-gated calcium channels associated with schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42814 Mon 05 Sep 2022 14:06:54 AEST ]]> Mapping genomic loci implicates genes and synaptic biology in schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49672 Fri 26 May 2023 15:35:47 AEST ]]> Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46603 Fri 25 Nov 2022 16:41:41 AEDT ]]> Transcriptomic Profiling of DNA Damage Response in Patient-Derived Glioblastoma Cells before and after Radiation and Temozolomide Treatment https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51740 Fri 15 Sep 2023 18:14:17 AEST ]]> Characteristics of vasculogenic mimicry and tumour to endothelial transdifferentiation in human glioblastoma: a systematic review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51543 Fri 08 Sep 2023 14:59:23 AEST ]]> Alteration of miRNA-mRNA interactions in lymphocytes of individuals with schizophrenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37045 Fri 07 Aug 2020 14:34:14 AEST ]]> Beyond the Global Brain Differences: Intra-individual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54564 Fri 01 Mar 2024 11:18:59 AEDT ]]>